Skip to main content
Livermore
Livermore
ZHEN

Ingalls & Snyder LLC

SEC CIK
0001041885
Latest filing
Aug 14, 2026

GSK holding history

GSK plc in every 13F filed by Ingalls & Snyder LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GSK overviewAll 13F holders of GSKFull Q2 2026 holdings

Shares (Q2 2026)
16,295
Value
$854.0K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of GSK by Ingalls & Snyder LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202616,295$854.0K<0.1%−177−1.1%ReducedHolders
Q1 202616,472$909.0K<0.1%00.0%UnchangedHolders
Q4 202516,472$808.0K<0.1%−47−0.3%ReducedHolders
Q3 202516,519$713.0K<0.1%−2,500−13.1%ReducedHolders
Q2 202519,019$730.0K<0.1%−160−0.8%ReducedHolders
Q1 202519,179$743.0K<0.1%−136−0.7%ReducedHolders
Q4 202419,315$653.0K<0.1%−8,340−30.2%ReducedHolders
Q3 202427,655$1.13M<0.1%−352−1.3%ReducedHolders
Q2 202428,007$1.08M<0.1%−640−2.2%ReducedHolders
Q1 202428,647$1.23M0.1%+1,600+5.9%AddedHolders
Q4 202327,047$1.00M<0.1%−3,848−12.5%ReducedHolders
Q3 202330,895$1.12M0.1%+2,253+7.9%AddedHolders
Q2 202328,642$1.02M<0.1%+1,480+5.4%AddedHolders
Q1 202327,162$966.0K<0.1%+542+2.0%AddedHolders
Q4 202226,620$935.0K0.1%−16,052−37.6%ReducedHolders
Q3 202242,672$1.26M0.1%−19,529−31.4%ReducedHolders
Q2 202262,201$2.71M0.1%−2,750−4.2%ReducedHolders
Q1 202264,951$2.83M0.1%−2,500−3.7%ReducedHolders
Q4 202167,451$2.98M0.1%−3,420−4.8%ReducedHolders
Q3 202170,871$2.71M0.1%−6,871−8.8%ReducedHolders
Q2 202177,742$3.10M0.1%−1,900−2.4%ReducedHolders
Q1 202179,642$2.84M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.